Bioinformatic analysis revealed increased expression of LYPD6 and LYPD6B mRNA expression in the brains of patients with different neurological and psychiatric disorders: autism, Huntington’s and Parkinson’s diseases, and in epilepsy (Fig. 1). Here, LYPD6B is linked to epilepsy.